Thursday, August 25, 2016

The real reason the EpiPen and other off-patents are so expensive

... role of patents and also FDA approvals in drug discovery and sales. Currently, a backlog of about 4,000 generic drugs is awaiting FDA approval. #EpiPen
EpiPen


No comments:

Post a Comment